{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:35:01Z","timestamp":1793064901343,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jss.2026.08.030","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:09:24Z","timestamp":1789510164000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Survival After Irreversible Electroporation in Unresectable Locally Advanced Pancreatic Cancer: A Meta-Analysis"],"prefix":"10.1016","volume":"327","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3294-4335","authenticated-orcid":false,"given":"Shahab","family":"Hajibandeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3316-7608","authenticated-orcid":false,"given":"Mariam","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kholoud","family":"Abu Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6317-2532","authenticated-orcid":false,"given":"Vaishnavi","family":"Sujathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1353-4381","authenticated-orcid":false,"given":"Louise M.","family":"Finch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-1068","authenticated-orcid":false,"given":"Shahin","family":"Hajibandeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinotha","family":"Nadarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Kadamapuzha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhalingam","family":"Jegatheeswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Jamdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Stathakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajith K.","family":"Siriwardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Satyadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"de Liguori Carino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2026.08.030_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1200\/JOP.2016.017376","article-title":"Locally advanced unresectable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary","volume":"13","author":"Balaban","year":"2017","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jss.2026.08.030_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17071197","article-title":"Technical feasibility of microwave ablation in pancreatic tumors: a scoping review of procedural efficacy and safety","volume":"17","author":"Tabacelia","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jss.2026.08.030_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000445021","article-title":"Ablation strategies for locally advanced pancreatic cancer","volume":"33","author":"Linecker","year":"2016","journal-title":"Dig Surg"},{"key":"10.1016\/j.jss.2026.08.030_bib4","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3748\/wjg.v20.i9.2267","article-title":"Systematic review of novel ablative methods in locally advanced pancreatic cancer","volume":"20","author":"Keane","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jss.2026.08.030_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.hpb.2021.12.014","article-title":"Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis","volume":"24","author":"Sugumar","year":"2022","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jss.2026.08.030_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133212","article-title":"Margin accentuation irreversible electroporation in stage III pancreatic cancer: a systematic review","volume":"13","author":"Ratnayake","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jss.2026.08.030_bib7","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000911","article-title":"Electroporation for the treatment of pancreatic ductal adenocarcinoma: a systematic review of preclinical and clinical studies","volume":"16","author":"Marcellier","year":"2025","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jss.2026.08.030_bib8","author":"Higgins"},{"key":"10.1016\/j.jss.2026.08.030_bib9","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jss.2026.08.030_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1620988","article-title":"Efficacy of irreversible electroporation combined with immunotherapy versus irreversible electroporation alone in locally advanced pancreatic cancer: a propensity score-matched retrospective study","volume":"16","author":"Xi","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jss.2026.08.030_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.14701\/ahbps.24-193","article-title":"Irreversible electroporation as an intraoperative adjunctive treatment for locally advanced pancreatic cancer after neoadjuvant therapy: an initial clinical experience","volume":"29","author":"Patel","year":"2025","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.jss.2026.08.030_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S2468-1253(24)00017-7","article-title":"MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial","volume":"9","author":"Timmer","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jss.2026.08.030_bib13","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1007\/s00330-024-10613-x","article-title":"Irreversible electroporation to bring initially unresectable locally advanced pancreatic adenocarcinoma to surgery: the IRECAP phase II study","volume":"34","author":"Tasu","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jss.2026.08.030_bib14","first-page":"29","article-title":"Irreversible electroporation in locally advanced pancreatic cancer","volume":"10","author":"Polyakov","year":"2023","journal-title":"Khirurgiia (Mosk)"},{"key":"10.1016\/j.jss.2026.08.030_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/MPA.0000000000002127","article-title":"Early single-center experience with irreversible electroporation for stage 2, 3, and 4 pancreatic adenocarcinomas","volume":"51","author":"Wall","year":"2022","journal-title":"Pancreas"},{"key":"10.1016\/j.jss.2026.08.030_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225677","article-title":"Safety and efficacy of irreversible electroporation in locally advanced pancreatic cancer: an evaluation from a surgeon's perspective","volume":"14","author":"Shen","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jss.2026.08.030_bib17","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/jso.27085","article-title":"Long-term follow-up experience with adjuvant therapy after irreversible electroporation of locally advanced pancreatic cancer","volume":"126","author":"Thomas","year":"2022","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3523769","article-title":"Simultaneous gemcitabine and percutaneous CT-Guided irreversible electroporation for locally advanced pancreatic cancer","volume":"2022","author":"Ma","year":"2022","journal-title":"J Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/COC.0000000000000826","article-title":"Irreversible electroporation (IRE) combined with chemotherapy increases survival in Locally Advanced Pancreatic Cancer (LAPC)","volume":"44","author":"Oikonomou","year":"2021","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.622318","article-title":"Survival comparison of neoadjuvant chemotherapy followed by irreversible electroporation versus conversional resection for locally advanced pancreatic cancer","volume":"10","author":"He","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib21","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.12998\/wjcc.v8.i22.5564","article-title":"Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer","volume":"8","author":"Ma","year":"2020","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jss.2026.08.030_bib22","first-page":"1643","article-title":"Efficacy of irreversible electroporation ablation combined with natural killer cells in treating locally advanced pancreatic cancer","volume":"25","author":"Pan","year":"2020","journal-title":"J BUON"},{"key":"10.1016\/j.jss.2026.08.030_bib23","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.jvir.2020.02.024","article-title":"Value of CT-Guided percutaneous irreversible electroporation added to FOLFIRINOX chemotherapy in locally advanced pancreatic cancer: a post hoc comparison","volume":"31","author":"van Veldhuisen","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jss.2026.08.030_bib24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1148\/radiol.2019191109","article-title":"Percutaneous irreversible electroporation in locally advanced and recurrent pancreatic cancer (PANFIRE-2): a multicenter, prospective, single-arm, phase II study","volume":"294","author":"Ruarus","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jss.2026.08.030_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/jcrt.JCRT_773_18","article-title":"Irreversible electroporation and adjuvant chemoradiotherapy for locally advanced pancreatic carcinoma","volume":"16","author":"Xu","year":"2020","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.jss.2026.08.030_bib26","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.21873\/anticanres.13371","article-title":"Percutaneous irreversible electroporation as first-line treatment of locally advanced pancreatic cancer","volume":"39","author":"M\u00e5nsson","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jss.2026.08.030_bib27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/00365521.2019.1575465","article-title":"Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility","volume":"54","author":"Flak","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jss.2026.08.030_bib28","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/OTT.S186721","article-title":"Irreversible electroporation combined with chemotherapy for unresectable pancreatic carcinoma: a prospective cohort study","volume":"12","author":"Liu","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jss.2026.08.030_bib29","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.2169\/internalmedicine.0861-18","article-title":"Irreversible electroporation for nonthermal tumor ablation in patients with locally advanced pancreatic cancer: initial clinical experience in Japan","volume":"57","author":"Sugimoto","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.jss.2026.08.030_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jso.25110","article-title":"The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma","volume":"118","author":"Huang","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.21037\/jgo.2018.01.14","article-title":"Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma","volume":"9","author":"Leen","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib32","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1007\/s00432-017-2513-4","article-title":"Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III\/IV) pancreatic cancer: a promising treatment","volume":"143","author":"Lin","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib33","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1245\/s10434-017-5900-9","article-title":"Induction chemotherapy followed by resection or irreversible electroporation in locally advanced pancreatic cancer (IMPALA): a prospective cohort study","volume":"24","author":"Vogel","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12032-017-0887-4","article-title":"Concurrent chemotherapy alone versus irreversible electroporation followed by chemotherapy on survival in patients with locally advanced pancreatic cancer","volume":"34","author":"Belfiore","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jvir.2016.10.023","article-title":"Percutaneous image-guided irreversible electroporation for the treatment of unresectable, locally advanced pancreatic adenocarcinoma","volume":"28","author":"Narayanan","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jss.2026.08.030_bib36","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.ejso.2016.01.024","article-title":"Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy","volume":"42","author":"M\u00e5nsson","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib37","first-page":"269","article-title":"Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience","volume":"63","author":"Lambert","year":"2016","journal-title":"Neoplasma"},{"key":"10.1016\/j.jss.2026.08.030_bib38","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1245\/s10434-015-5034-x","article-title":"Single-institution experience with irreversible electroporation for T4 pancreatic cancer: first 50 patients","volume":"23","author":"Kluger","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2026.08.030_bib39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SLA.0000000000001441","article-title":"Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy","volume":"262","author":"Martin","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2026.08.030_bib40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000375323","article-title":"Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study","volume":"32","author":"Paiella","year":"2015","journal-title":"Dig Surg"},{"key":"10.1016\/j.jss.2026.08.030_bib41","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1245\/s10434-019-07261-7","article-title":"Systematic review of surgical and percutaneous irreversible electroporation in the treatment of locally advanced pancreatic cancer","volume":"26","author":"Moris","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426005408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426005408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:23:37Z","timestamp":1793064217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480426005408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S0022480426005408"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2026.08.030","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival After Irreversible Electroporation in Unresectable Locally Advanced Pancreatic Cancer: A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2026.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}